CALC
NASDAQCalciMedica Inc.
CalciMedica Inc. (CALC) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for CALC, including 1 SEC filing, 1 press release or news item and 1 insider trade. The most recent was published Nov 5, 2026.
Financial highlights
Full financials- Net income, TTM
- -$21.24M
- Free cash flow, TTM
- -$19.12M
- Cash
- $18.62M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks54-85%
2026-05-172026-11-08
Mix3590d
- Insider19(54%)
- SEC Filings9(26%)
- Other6(17%)
- Analyst1(3%)
Activity · 52 weeks7534 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- INSIDERCHIEF BUSINESS OFFICER Roberts Eric W was granted 180,000 employee stock options (SEC Form 4)4 - CalciMedica, Inc. (0001534133) (Issuer)
- PRCalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceLA JOLLA, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that Management will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tuesday, November 10, 2026, at 9:30 a.m. ET. A live webcast of the presentation can be accessed in the "IR Events and Presentations" section of CalciMedica's IR website. A replay of the webcast will be archived on the Company's website for 90 days
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- SECSEC Form 424B5 filed by CalciMedica Inc.424B5 - CalciMedica, Inc. (0001534133) (Filer)
- INSIDERSEC Form 4 filed by Chief Medical Officer Hebbar Sudarshan4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Chief Scientific Officer Stauderman Kenneth A.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Bardin Stephen4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CHIEF EXECUTIVE OFFICER Leheny A. Rachel4 - CalciMedica, Inc. (0001534133) (Issuer)
- SECSEC Form S-8 filed by CalciMedica Inc.S-8 - CalciMedica, Inc. (0001534133) (Filer)
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- PRCalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceLA JOLLA, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that Management will present and participate in 1x1 investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026. About CalciMedicaCalciMedica is a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunolog
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- PRCalciMedica Announces One-for-Five Reverse Stock SplitLA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5, effective at 5:00 p.m. ET on August 28, 2026. CalciMedica’s common stock will begin trading on the Nasdaq Capital Market on a split-adjusted basis commencing upon market open on August 31, 2026 under CalciMedica’s existing trading symbol "CALC" with a new
- SECSEC Form SCHEDULE 13G filed by CalciMedica Inc.SCHEDULE 13G - CalciMedica, Inc. (0001534133) (Subject)
- INSIDERSEC Form 4 filed by Large owner Alafi Capital Co Llc4 - CalciMedica, Inc. (0001534133) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by CalciMedica Inc.SCHEDULE 13D/A - CalciMedica, Inc. (0001534133) (Subject)
- INSIDERSEC Form 4 filed by Director Shaw Allan4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Director Glicklich Alan4 - CalciMedica, Inc. (0001534133) (Issuer)
CALC FAQ
9 questionsWhat is the latest news on CALC?
In the last 30 days Quantisnow tracked 3 wire items for CALC: 1 SEC filing, 1 press release or news item and 1 insider trade. The most recent was published on November 5, 2026.Is CALC profitable?
No. CalciMedica Inc. reported a net loss of $21.24M for the twelve months ended Jun 30, 2026.How much cash and debt does CALC have?
CalciMedica Inc. reported $18.62M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does CALC stock trade?
CalciMedica Inc. (CALC) is listed on NASDAQ.What sector and industry is CALC in?
CalciMedica Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did CalciMedica Inc. go public?
CalciMedica Inc. (CALC) completed its IPO in 2023.What are analysts saying about CALC?
Across the last 2 analyst actions on CalciMedica Inc., there were 0 upgrades and 1 downgrade. The most recent action was from Guggenheim: Buy with a $9.00 price target on 2026-08-20. Recent price targets cluster around $9.00.What companies are similar to CALC?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare CALC side-by-side with any of them on Quantisnow.How can I track CALC on Quantisnow?
Quantisnow aggregates CalciMedica Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CALC to receive live email and push alerts on every new disclosure.